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Background: Innovative strategies are needed to tackle childhood mortality in the rural tropics. Artesunate
suppositories were developed to bring emergency treatment closer to severely ill children with malaria in rural
areas where injectable treatment is not possible for several hours. Adding an antibacterial rectal drug would extend
this strategy to treat non-malarial febrile illness as well. The objective of these studies was to assess acceptability of
such a new pre-referral strategy by healthcare providers and likely uptake by the population.
Methods: Two qualitative studies were conducted between May and July 2009. Study 1 investigated the
acceptability of introducing a combined antimalarial-antibacterial suppository by interviewing 27 representatives of
the three administrative levels (central government, regional, local) of the health sector; Study 2 investigated
treatment-seeking behaviour and acceptability of this intervention at community level by interviewing 74 mothers
in 2 villages.
Results and Conclusions: Up to 92% of health representatives were in favour of introducing a new pre-referral
strategy to tackle both malaria and non-malaria related severe illnesses in Guinea-Bissau, provided it was endorsed
by international health authorities. The main obstacles to implementation were the very limited human and
financial resources. In the two villages surveyed, 44% of the mothers associated severe illness with fever only, or
fever plus one additional symptom. Mothers’ judgement of severity and ensuing decisions were not specific for
serious illness, indicating that initial training to recognize signs of severe disease and treatment availability for
non-severe, fever-associated symptoms will be required to prevent overuse of a new intervention designed as a
pre-referral treatment for severely ill children. Level C health centres were the first resort in both villages (50% and 87%
of respondents respectively). This information is encouraging for the implementation of a pre-referral treatment.
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It has been estimated that Plasmodium falciparum mal-
aria and acute respiratory infections (ARI) together ac-
count for 25% of childhood deaths worldwide. The
clinical manifestations of malaria and ARI are often
similar, which tends to lead to frequent overdiagnosis of
malaria [1,2]. The health of a febrile child can deterior-
ate very rapidly and a large number of the deaths in
rural areas occur before patients have reached a health
care facility. In Tanzania, up to 40% of children who die
have never been seen in a health centre; in Bolivia this
figure approaches 74% [3]. In severe falciparum malaria,
the risk of death increases in line with the delay in ad-
ministering an effective anti-malarial drug and is max-
imal in the first 24 hours. Therefore, the speed at which
appropriate management is instituted is the key factor
influencing the outcome of treatment. Administration of
rectal artesunate as a pre-referral treatment was evalu-
ated in a large randomized, placebo-controlled trial
of more than 12,000 malaria patients conducted in
Bangladesh, Ghana and Tanzania. Such treatment re-
duced death or permanent disability in patients with se-
vere malaria who experienced delays greater than six
hours in reaching a health care facility [4]. Pre-referral
treatment with a single dose of rectal artesunate has
been introduced within the Integrated Management of
Childhood Illnesses (IMCI) in remote areas.
Knowing that a sizeable proportion of deaths in young
children labelled as malaria are probably the result of
bacterial sepsis, in particular pneumonia, there is a
strong argument for extending the strategy of emergency
pre-referral treatment to antibacterial as well as anti-
malarial therapy by co-formulating an antibiotic with an
artemisinin derivative in suppository form [5,6]. Such a
product has the potential to reduce mortality by redu-
cing the delays in antibiotic treatment among children
who can no longer take oral antibiotics.
Effectiveness of this strategy under real-life conditions
not only depends on demonstrating efficacy of the for-
mulation but ensuring access to treatment among re-
mote populations who are likely to benefit most from
this kind of intervention is a major challenge. This
process starts with the incorporation of the new treat-
ment into a country’s policy. Thereafter, a continuous
supply of the drug in areas of need, should be estab-
lished. In the rural tropics the nearest health centre is
often several miles away from a village, thus the speed of
detecting serious illness and patterns of treatment-
seeking behavior that emphasize treatment and referral
will also be factors affecting how a policy performs in
practice.
The main objectives of this case study, which took
place between May and July 2009, were: (i) to evalu-
ate the acceptability of a proposed strategy of rectalantimalarial-antibacterial pre-referral treatment at all
levels of the health sector; (ii) to evaluate the know-
ledge, attitudes and practices of mothers and primary
health care staff confronted with febrile illness in
children in rural areas in order to define implementa-
tion of home-based pre-referral treatment.
Guinea-Bissau was chosen because it has a high mal-
aria prevalence and limited access to health structures
for the majority of the population who live in rural areas
(64%) [7]. The average life expectancy is 46 years and
Guinea-Bissau ranked 164 out of 169 countries in the
2010 Human Development Index [8].
Infectious diseases account for most health care con-
sultations, in particular malaria, ARI, diarrhoeal disease,
HIV and tuberculosis. The first three of these account
for 65% of deaths in children less than five years of age.
More than 50% of medical consultations are for malaria,
and the country reported 50 deaths for 100 000 admissions
to health care facilities in 2012. Artemether – lumefantrine
is the recommended treatment for uncomplicated malaria.
Intra-venous quinine is the recommended treatment for
severe malaria. ARI represents the second most common
cause of death in children aged less than five years in
Guinea-Bissau [9].
Methods
Two qualitative studies were performed:
Study 1 – Interviews with health sector representatives
Public health structure
The organization of the national public health service is
pyramid-shaped with three levels, local, regional and
central. The central level is represented by the Ministry
of Public Health (MPH) and consists of the Office of
Services, the National Programmes, Simão Mendes Na-
tional Hospital and other national specialized hospitals
and centres. The central level draws up policies and
strategies, regulates health care activities and coordinates
external aid. The regional level is represented by the Re-
gional Hospital, Regional Health Office and regional
health care teams. It is in charge of implementing the
annual programme. At the local level, the health struc-
tures provide primary care and consist of Levels A, B or
C depending on geographical location, access to a re-
gional hospital, and size of population served:
 A: may serve also as secondary level of care,
physicians, nurses, clinical, surgery and some
laboratory diagnosis, referral system for the regional
hospitals;
 B: secondary level of care, physicians, nurses, clinical
and basic laboratory diagnosis;
 C: primary level of care, nurses only, first contact
between community members and other levels of
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laboratory diagnosis.
These health care facilities are managed by a technical
team and management committee. Representatives of
the three levels of the health sector were interviewed
(Table 1). The total number of respondents was 27.
Study 2- Interviews with mothers, community health
workers, and health professionals from level C and B
health care facilities (in rural Guinea-Bissau)
Selection of the community study sites and randomization
Tchale and Bantandjan villages in Oio region were se-
lected. They were two of the furthest villages from a
health centre with laboratory diagnostic facilities and
ability to administer injectable treatment. The target
population of this survey was mothers of children under
five years of age. Inclusion criteria were availability dur-
ing the study and informed consent of respondents. The
sample size was 40 mothers per village.Table 1 Description of interviewees in Study 1
Category of respondent Organization/Department
Representatives of the Health Departments
at central/government level
Department of Family Healt
National Malaria Control Pro
National Programme For He
National Programme For He
Department of Primary Heal
Department of Pharmacy an
CECOME*
Representatives of the Health Departments
at regional level
Regional departments of He
CECOME* regional depot/di
Mansoa







National Programme For He
Plan International
WHO Guinea-Bissau
Health professionals at different levels Simao Mendes National Hos
Mansoa Regional Hospital
Farim Health Centre (Type A
Bissora Health Centre (Type
Health Centre (Type C)**
*CECOME Central de Compra de Medicamentos (Central Office for Purchasing of Es
**Health centre Type A, B or C: classification of primary health care centre accordin
some surgery.Tchale village has around 1,000 inhabitants, mainly an-
imists of the Balante ethnic group, and is situated 90 mi-
nutes (by foot) from a Level C health centre and three
hours (by foot + car) from Bissora sector Level B health
centre. The nearest health care facility able to manage
severe malaria or ARI is Bissau National Hospital, three
hours away from the village by road.
Each village consists of 32 plots distinct from each
other; the number of houses per plot may vary from
two to 21. At least one woman per plot and two women
in larger plots were interviewed in order to reach a tar-
get of 40 respondents. Most women interviewed had
never attended school. Apart from picking cashew nuts
during the harvest season, most had no income-
generating activities. The survey was conducted during
the cashew nut harvest so many women were not at
home. Thirty six housewives were interviewed in Tchale
village, on the assumption that field- and home-
working mothers shared responsibilities and income
from each plot equally.Position Number
h Director 1
gramme Director 1
alth Development Director of national control programme
for malaria, HIV and tuberculosis
1
alth Development Responsible for cost recovery 1
th Care Director 1
d Medicines Assistant Director 1
Director 1
alth Oio Region Director and Assistant Director 2
stribution centre, Manager 1
Head of Department of Communicable
Disease Control
1
WHO representative in Guinea-Bissau 1
Medical coordinators 2




alth Development Global Fund representative 1
Medical coordinator 1







g to activity. Level A has the most complete package of care including
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nutes by car from a Level C health centre. The nearest
reference structure is Mansoa Regional Hospital, situated
between two hours and 15 minutes and eight hours
from the village, depending on the type of transport
used. Bantandjan has about 350 inhabitants who are
mainly Muslims from different ethnic groups: Mandigoes,
Manjaques, Mansanques, Pepels, and Balantes. The village
is made up of 52 houses. One woman was interviewed
in each of 40 households selected at random from a list
of all village homes. Most women interviewed had never
attended school. Apart from the palm oil harvest, they
had no income-generating activities. The survey took
place during palm oil season and 38 mothers were inter-
viewed in Bantandjan village.
In each health area, but not in each village, there is
community health services called Basic Health Struc-
tures (BHS), managed by Community Health Workers
with very basic health training (no health related
diploma), and traditional midwifes. The health care facil-
ities selected for the study were close to Tchale and
Bantandjan: four BHS, one Level C and one level B
health centres surveyed and named by the mothers. The
respondents of the health centre survey were health pro-
fessionals in charge of these facilities. They were Com-
munity health Workers in BHS, nurses in in level C, and
one doctor in level B health centres.
Interview methodology
For both studies, interviews were semi-structured and
conducted with the help of pre-prepared interview
guides. The language of the interviews was French at the
central level and Portuguese Creole at the regional and
local levels, via translators. For study 1, open questions
were used to evaluate acceptability of a pre-referral
treatment at all health care levels. For study 2, open
questions were used to evaluate the knowledge of the
respondents of severely ill febrile children, and closed
questions were used to define their attitudes and prac-
tices for treatment. The data collection tools were pre-
tested in Bissau rural areas.
Data analysis
Interviews were transcribed verbatim. Data collected was
categorized by theme. Specific comments were selected
either because they were repeated frequently or because
they best reflected the overall opinion of the respondents
on a specific topic.
Ethical approval
The study protocol was approved by the Ethical Com-
mittee of the Department of Hygiene and Epidemiology
of the Ministry of Health in Guinea-Bissau. Study partic-
ipants were given a document outlining the backgroundand aims of the project. Verbal consent was obtained
before each interview. For interviews that were tape-




Acceptability of the proposed strategy of a combined
antimalarial-antibacterial emergency pre-referral treatment
All respondents judged that the proposed strategy was
suitable for the epidemiological context in Guinea-
Bissau for children less than five years of age. Several in-
terviewees stressed their interest in having a combined
medicine capable of treating both malaria and respira-
tory infections as a strategy to combat high childhood
mortality rates. Some respondents remarked upon the
pertinence of proposing a treatment which contains
medicines already well known and conforming to the
treatment protocols in place in the country, and in a
form more suitable for young children than tablets. Ac-
cording to one paediatrician, the idea of a co-formulated
treatment was particularly suited to Guinea-Bissau since
there was already a national move towards integrated
management of sick children for both malaria and re-
spiratory infections in malaria-endemic regions. The
current national health policy for rural areas has been
trying to revive and strengthen the most basic peripheral
health posts in an attempt to bring emergency treatment
to the village level. Several respondents stressed the diffi-
culties of geographical access that delay the arrival of
patients at health care facilities, particularly during
the rainy season. According to one respondent, a pre-
referral treatment at community level might also help to
counteract the delay in seeking treatment related to cul-
tural practices:
‘At community level there are cultural difficulties
because it is up to the father to take the decision to
bring the child to a health centre. The mother waits
for her husband to decide; that can take some time.
This situation would justify the use of a pre-referral
treatment in the community.’
The interviewees were aware that such a strategy
would comply with WHO recommendations to use rec-
tal artesunate as emergency treatment.
For 23 out of 25 respondents (92%) administration of
a combined antibiotic-anti-malarial treatment would be
an acceptable solution for the emergency pre-referral
treatment of children aged less than five years. One sin-
gle reservation mentioned was the risk that the advice to
seek further treatment at a health centre would not be
followed by parents once the suppository had been
administered.
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the strategy from a public health point of view in a con-
text where there was no alternative. One of the paedia-
tricians felt that a combination treatment containing
an antibiotic would be an advance compared to giving
artesunate alone. In practice, certain medicines are
already given by the rectal route (quinine, phenobarbit-
one, paracetamol) without problems. The availability
of a heat-stable suppository to treat children was con-
sidered advantageous. Some health professionals under-
lined the importance of giving clear information to
mothers and community health workers on the use
of this route of administration in order for it to be
adopted easily.
Conditions for use of a combined antimalarial-antibacterial
suppository formulation
According to the representatives of the various health-
related institutions interviewed (six respondents), the
introduction of such a treatment into the country
would necessitate a modification of the policy for the
management of malaria in children. This would imply
an application to include the new medicine into the
National List of Essential Medicines and the treatment
policy documents of the National Malaria Control
Programme and Integrated Management of Childhood
Illness. This would be conditional on the identification
of partners with the necessary financial and technical
expertise.
The interviewees also discussed factors affecting access
to treatment by the target population. Three main as-
pects were highlighted:
 For a large majority of the respondents, cost was the
major determinant of accessibility to medicines.
They referred to the strategy implemented to make
Coartem® affordable to the population:
‘The cost of the new medicine must not be higher than
the cost of Coartem® ..(…) We know how much the
population is able to pay and not all of them can
afford Coartem®. We cannot give the medicine free of
charge but the price must not be an obstacle.’Half of the participants interviewed believed that a
subsidy of a new medicine would be necessary in
order to ensure accessibility.
 Half of those interviewed cited availability of the
medicine as an important condition to ensure access
to treatment. For them, the assurance of a regular
supply from the manufacturer to the village was
vital, with a reliable distribution system.
 Two of 6 respondents felt that access to the
medicine should be guaranteed by the communityhealth workers and basic health care units that are
closest to the population.
In summary, the conditions necessary for the imple-
mentation of a new treatment in the health sector iden-
tified were:
 Demonstration of efficacy and/or heat stability (five
respondents)
 Integration into the national treatment protocols
(six respondents)
 Validation of the treatment by WHO (two
respondents)
 Information, education and communication
campaigns aimed at the population (18 respondents)
 Training, information and remuneration of the
health technicians (18 respondents)
 Follow-up and supervision of the community health
workers (five respondents)
 Population payment (token payment) towards the
cost of the medicine (one respondent)
Objections, obstacles and difficulties anticipated for
introduction in the country and for its use at community
level
Interviewees postulated potential obstacles to the intro-
duction of a medicine at the community level as follows:
 Poor availability of personnel at the community
level: community health workers are already
overworked and very often they do not stay a long
time in the same village (four respondents)
 Financial difficulties of the population in rural areas
which could prevent referral to health centres,
because of transport, consultation and
accommodation costs (three respondents)
 If the constituents of a new product were not
already part of the national treatment policy for
treatment of malaria and respiratory infections it
would be difficult to get approval (three
respondents)
 The administrative and financial burdens incurred
when a new medicine is introduced into the national
policy (two respondents)
 Cultural obstacles: reliance on traditional healers by
the population in some areas (two respondents)
 The difficulties of ensuring a regular supply of a new
medicine, particularly if the process involves
external donors, as seen with the introduction of
artemether – lumefantrine (Coartem®) financed by
the Global Fund (one respondent)
 Problems of access to treatment in villages where
there is no community health worker (one
respondent)




% Tchale % Bantandjan
(n = 36) (n = 38)
Home treatment 5.6 2.7
Traditional practitioner 27.8 10.5
Level C health centre 50.0 86.8
Level B health centre 11.0 0
National Hospital 5.6 0
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proposed with the planned introduction of rapid
diagnosis tests for malaria in the peripheral health
posts (one respondent).
Study 2
Knowledge, attitudes and practices of mothers faced with a
seriously ill febrile child Tchale village (36 respondents)
Knowledge of mothers regarding serious conditions
in children When asked to describe the signs and
symptoms of a seriously ill child who may be dying, out
of 36 mothers, 22.2% quoted fever only and 36% quoted
fever plus one or more other symptoms Table 2).
Attitudes and practices of mothers regarding serious illness
in children
Treatment of first resort When presented with a hypo-
thetical situation in which their child is in a serious
condition (febrile and cannot swallow) and asked to
describe their first care-seeking response, 50% of 36
mothers said they would go to the Level C health centre
and 27.8% answered that they would consult a trad-
itional practitioner first (Table 3).
Various treatment-seeking behaviours described by the
mothers for the treatment of their child and justification
When asked what they would do if their child was
not cured after the first care-seeking response, most
of the women who had opted for the traditional prac-
titioner chose to go to a Level B or C health centre
(Figure 1 and Table 3). For these women, the fact
that the treatment provided by the traditional practi-
tioner did not cure the child meant that the disease
was not of spiritual origin.
Out of the 22 women who opted for a Level B or
C health centre for the initial treatment, 31.8% said
they would choose to consult a traditional healer next,
while 50% would go to a higher level facility if theTable 2 Signs and symptoms of serious illness reported







Fever only 22.2 (8) 7.9 (3)
Fever plus another symptom 22.2 (8) 36.8 (14)
Fever plus two other symptoms 8.3 (3) 18.4 (7)
Fever plus three other symptoms 5.5 (2) 2.6 (1)
Other symptoms – without fever 30.6 (11) 15.9 (6)
Don’t know 11.2 (4) 18.4 (7)
Total 100 (36) 100 (38)
Other symptoms: fatigue, vomiting, diarrhoea, anorexia, respiratory distress,
prostration, convulsion, headache, icterus, pale face.child had not improved after being treated in a Level
C health centre.Time spent in the village before departing for a health
structure and justification
The delay before departing for a health facility varied
from zero to seven days. The average lapse of time was
2.13 days (standard deviation = 1.58). Reasons given for
the time delays were:
 To find money for consultation fees and drugs (83%
of respondents)
 To find money for transport (61% of respondents)
 To find a means of transport (25% of respondents)
 To wait for the family decision-maker (2% of
respondents)
 To be available to go (2% of respondents)
 Other (2% of respondents)
Two women stated they would not encounter any
problems and could leave the village whenever they
wanted to. Four mothers mentioned the need for a spir-
itual ceremony as one of the reasons for a delayed de-
parture to a health facility.Bantandjan village (38 respondents)
Knowledge of mothers regarding serious conditions
in children Of 38 mothers, 7.9% quoted fever only and
57.8% quoted fever plus one or more other symptoms.
All mothers considered that a child unable to eat or
drink was in a severe state (Table 3).Attitudes and practices of mothers regarding serious
conditions in children
Selection of the treatment of first resort Out of 38
mothers, 86.8% said they would go to the Level C health
centre and 10.5% answered that they would consult a
traditional practitioner as a treatment of first resort
(Table 3).
Figure 1 Patterns of treatment-seeking behaviour described by the mothers in Tchale.
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mothers for the treatment of their child and justification
The various itineraries described by the mothers with
explanation are presented in Figure 2 and Table 3. The
four women (11%) who opted for the traditional healer
as a first resort would go to a Level C health structure
if the child had not been cured by traditional cere-
mony. Of the 87% of women who opted for a Level C
health centre as treatment of first resort, 6% would
choose to consult a traditional practitioner and 67%
would go to the regional or national hospital to have
their child treated.
Time spent in the village before departing for a health
facility and justification
The time delay in the village before departing for a
health facility was shorter than in Tchale and ranged
from zero to four days. The average lapse of time re-
ported was 1.34 days (SD = 0.91). Reasons given for the
delay were:
 To find money for consultation fees and drugs (97%
of respondents) To find money for transport (97 of respondents)
 To find a means of transport (97 of respondents)
Only one respondent asserted that she would not en-
counter any problem.
Knowledge, attitudes and practice of staff of primary
healthcare facilities managing complicated febrile illness
in children
In order to provide complementary information, BHS,
level C and one level B health care facilities were vis-
ited. In each of them, the person in charge was asked
about his or her knowledge of serious conditions in
children.
Features of a serious condition
The staffs in charge of health facilities were asked to de-
scribe the characteristic symptoms of a serious condition
in children, apart from high fever. The respondents of
the Level C health centres quoted convulsions and two
of them also mentioned loss of consciousness. One doc-
tor mentioned lethargy, facial oedema, vomiting, diar-
rhoea, loss of appetite, and weight loss. The community
Figure 2 Treatment-seeking behaviour described by the mothers in Bantandjan.
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coughing, vomiting and diarrhoea.
Differential diagnosis for malaria and acute respiratory
infections
BHS and level C health facilities did not have the cap-
acity to carry out laboratory diagnosis and the commu-
nity health officer had no knowledge of malaria rapid
diagnostic tests (RDTs). Only one health centre had the
necessary equipment to perform a blood smear. The
diagnosis of ARI or malaria was based on clinical assess-
ment in the three health facilities visited. In BHS, out of
four health professionals interviewed, two did not know
about RDTs. Indeed, RDTs were not part of the list of
medical equipment provided to BHS or first level C
health centres. Each health officer had a different de-
scription of ARI and malaria symptomatology, althoughin most cases fever was associated with malaria while
cough and abnormal respiratory rate were associated
with ARI.
Description of health care provision
When a febrile child who cannot swallow consults a
BHS, the community health officer systematically refers
him to the nearest health centre. No treatment is admin-
istered to the child before referral. In the Level C health
centres unable to perform laboratory diagnosis, basic re-
suscitation is provided and a child is then sent to the
nearest reference health centre. At one of those centres
the only pre-referral treatment received by a child is di-
azepam given by intramuscular (IM) injection in case of
convulsions. The nurse then refers the child, which in
most cases means the mothers have to walk carrying
their child to the referral facility. In the other two
Vermeersch et al. Malaria Journal 2014, 13:50 Page 9 of 10
http://www.malariajournal.com/content/13/1/50centres, the treatment of a febrile child unable to swal-
low usually consists of a quinine drip with 5% glucose.
In one of those centres, the staff will also administer
paracetamol by IM injection or as an addition to the
parenteral solution. Referral is immediate, or within an
hour of receiving intravenous (IV) therapy depending on
the centre. In health centres managed by a doctor, the
child is treated on site. On arrival, the child receives
symptomatic presumptive care, while waiting for the re-
sult of blood smear test. The treatment consists of IM
injections of paracetamol and/or diazepam in case of
convulsions. If the blood smear is positive, the child is
treated according to the treatment protocol for severe
malaria, i e, IV quinine with 5% glucose. If the blood
smear test is negative, the doctor tries to diagnose alter-
native pathologies depending upon the clinical presenta-
tion. If the child is assessed as having acute respiratory
infection, treatment is normally ampicillin IV injection
for seven days. The child is put under observation in the
health centre for two days. If there is no improvement
after two days, the family is referred to Simao Mendes
National Hospital in Bissau.
Discussion
The proposed strategy of introducing a combined
antimicrobial-anti-malarial emergency pre-referral treat-
ment was acceptable by health sector representatives
and was felt to be well adapted to the context in
Guinea-Bissau. This approach was also considered to fit
well with the current move to revitalize the most periph-
eral health facilities and would be in line with WHO rec-
ommendations for the use of pre-referral treatment with
rectal artesunate [10]. Use of the rectal route to deliver
medicines was not perceived to present a problem and
in fact this approach was considered to fill a gap since,
currently, there is no emergency treatment option avail-
able for sick febrile children in remote areas of Guinea-
Bissau.
In studying the knowledge, attitudes and practices of
mothers in Tchale and Bantandjan villages and health
professionals in the nearest primary health care facilities,
the objective was to describe the real conditions in
which any future pre-referral rectal treatment would be
used. The questionnaire did not intend to investigate the
perception of intra-rectal drug administration at the vil-
lage level. Nevertheless, informal discussion with the
health representatives indicated that rectal administra-
tion of drugs was not a problem in the country. Similar
compliance to rectal administration has been described
in other West African countries [11,12]. However, a
study performed in Laos indicated reluctance by the Lao
community to use the rectal route, thus highlighting the
need to take in account local behaviour before introdu-
cing a new therapy [13].In Guinea-Bissau, all mothers acknowledged that chil-
dren who could not swallow were in a serious condition.
On the other hand, some mothers described such a var-
iety of signs of illnesses that there would be a real risk
that an emergency treatment might be too late and thus
not guarantee a child’s survival during transportation to
the reference health centre if its use was restricted to
very severe cases. If a new treatment does not prove its
efficacy, there is a possibility it might not be accepted by
the community.
As for the treatment-seeking behaviour, 66.7% of the
mothers interviewed in Tchale and 86.8% of those inter-
viewed in Bantandjan declared they would go to a health
structure when their child was in a serious condition.
These women were not opposed to a pre-referral emer-
gency drug treatment readily for their child. However,
27.8% of the mothers interviewed in Tchale and 10.5%
of those interviewed in Bantandjan said they would
first opt to consult a traditional healer. Tchale mothers
selected this option for cultural reasons despite the
proximity of a level C health centre, compared to Ban-
tandjan. It is possible that the mothers with strong spir-
itual beliefs would be more reluctant to accept the
administration of the drug as the treatment of first re-
sort. Indeed, a study conducted in Tanzania on rectal
artesunate has shown that the perception of the causes
of the diseases might influence the implementation of an
early treatment [14]. Bantandjan women chose to con-
sult a traditional healer mainly because there was no
level C health facility in the village and access to the first
health centre was difficult for geographical or financial
reasons. It is anticipated that these women would not be
so reluctant to consult a community health worker in
charge of dispensing a life-saving drug in the village.
Most of the Tchale mothers and all of the Bantandjan
mothers making the trip to the health centre chose a
Level C health centre. A survey in these facilities showed
that, in most cases, the Level C health centre does not
have the capacity to perform laboratory diagnosis, or to
initiate appropriate drug treatment. Furthermore, most
of these centres refer seriously ill children to the next fa-
cility after dispensing emergency first aid.
We did not probe the fact that, by definition, pre-
referral treatment would need to be followed by referral
to a health facility in our study. Yet, provision of rectal
artesunate or a combination-therapy that treats both
malaria and ARI with emergency pre-referral combin-
ation therapy treatment, means that a suppository dis-
penser in the village would have to direct the mothers
towards a Level A or B health centre or the hospital.
Consequently, mothers of treated children would need
to accept the need for referral and agree to facilitate
transit of the child to referral facilities which are located
further from the village than basic health units. A study
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after pre-referral treatment in Tanzania has shown that
if the child presents signs of serious illness such as coma
or convulsions, transit to a referral health facility was in-
creased three-fold [15]. Our results here show that there
can be a substantial time delay before departing to a
health facility (average of 2.13 days in Tchale and
1.34 days in Bantandjan) because of poor transport and
lack of money. Even if the treatment was available in the
village, mothers of sick children would still need to com-
ply with referral advice- and mechanisms for facilitating
referral were not explored in our study.Conclusion
Guinea-Bissau has the infrastructure necessary to make a
new medicine available at community level. The condi-
tions for introducing a new treatment were clearly laid
down by study respondents and related to properties of
the medicine itself (efficacy, heat stability, cost, availability,
validation by health authorities) and its integration into
the health system (revitalization and expansion of the net-
work of health care providers at community level, avail-
ability and training of health care workers). The ability of
mothers to recognize early signs of severe illness is a key
factor favouring use of pre-referral treatment. On the
other hand, this would imply providing, in parallel, oral
artemisinin-combination treatment for mild malaria to re-
duce the evolution of disease to severe malaria, and early
diagnosis and treatment of pneumonia via oral antibiotics
to prevent evolution to severe pneumonia.
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